Wolverine Asset Management
PBMWW icon

Wolverine Asset Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Wolverine Asset Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3K Sell
142,995
-4,106
-3% -$113 ﹤0.01% 1596
2026
Q2 		$3.58K Hold
147,101
– – ﹤0.01% 1507
2026
Q1 		$2.68K Hold
147,101
– – ﹤0.01% 1533
2025
Q4 		$2.72K Hold
147,101
– – ﹤0.01% 1522
2025
Q3 		$3.71K Hold
147,101
– – ﹤0.01% 1452
2025
Q2 		$2.99K Hold
147,101
– – ﹤0.01% 1458
2025
Q1 		$2.49K Hold
147,101
– – ﹤0.01% 1418
2024
Q4 		$2.12K Hold
147,101
– – ﹤0.01% 1478
2024
Q3 		$1.85K Hold
147,101
– – ﹤0.01% 1482
2024
Q2 		$1.54K Buy
147,101
+12,184
+9% +$677 ﹤0.01% 1511
2024
Q1 		$9.44K Buy
+134,917
New +$8.4K ﹤0.01% 1305

Other funds holding PBMWW

Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Wolverine Asset Management's PBMWW Position: Q3 2026 in Review

Wolverine Asset Management reduced its Psyence Biomedical Warrant (PBMWW) stake by 2.8% in Q3 2026, selling an estimated $113 and leaving 142,995 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Wolverine Asset Management first reported a position in PBMWW in Q1 2024 and has held it in 11 quarters since. The position peaked at $9.44K in Q1 2024. 3 funds tracked by Wall St. Rank hold PBMWW as of Q3 2026.

  • Wolverine Asset Management held 142,995 shares of Psyence Biomedical Warrant worth $3K as of Q3 2026.
  • Wolverine Asset Management sold 4,106 Psyence Biomedical Warrant shares in Q3 2026, an estimated $113.
  • Psyence Biomedical Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #1596 holding.
  • Wolverine Asset Management first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 11 quarters since.
  • Wolverine Asset Management's Psyence Biomedical Warrant position peaked at $9.44K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.